Overview

60 Second Summary

Urinary incontinence is a common and distressing condition affecting a significant proportion of adult women in Ireland. It is defined as the involuntary leakage of urine and occurs when the normal processes of bladder filling, storage and emptying are disrupted. Although prevalence increases with age, incontinence is not an inevitable part of ageing and can affect women at all stages of life, including during pregnancy, after childbirth and following menopause. The condition can have a profound impact on quality of life, leading to physical discomfort, sleep disturbance, social withdrawal and psychological distress.

There are several types of urinary incontinence, most commonly stress, urge and mixed incontinence. Stress incontinence results from weakness of the pelvic floor and urethral sphincter and is triggered by activities that increase intra-abdominal pressure, such as coughing or exercise. Urge incontinence is caused by involuntary contractions of the detrusor muscle and is characterised by sudden urgency, frequency and nocturia. Overflow and continuous incontinence are less common but may occur in the presence of bladder outlet obstruction, neurological disease or sphincter damage.

Community pharmacists play a key role in the identification and management of urinary incontinence. Through sensitive consultation, pharmacists can assess symptoms, review medicines that may contribute to bladder dysfunction and provide advice on lifestyle modification, including fluid management, caffeine reduction, weight control and pelvic floor muscle training. Pharmacists also support appropriate use of pharmacological therapies for overactive bladder, recommend suitable continence products and provide guidance on skin care and catheter management where required. By offering accessible, confidential and evidence-based support, community pharmacists can help reduce stigma, encourage early intervention and significantly improve quality of life for women living with urinary incontinence.

Pharmacy Management of Adult Female Urinary Incontinence in Ireland

Introduction

Urinary incontinence is defined as the involuntary leakage of urine and occurs when the normal processes involved in bladder filling, storage and emptying are disrupted. It is a highly prevalent condition affecting millions of women worldwide and a significant proportion of women in Ireland. Although the prevalence increases with age, urinary incontinence is not an inevitable consequence of ageing and can affect women at all stages of life, including during pregnancy, the post-partum period and the menopausal transition. Despite its frequency, many women do not seek help, often due to embarrassment, fear of stigma or the belief that incontinence is a normal part of ageing or childbirth that must simply be endured.

The impact of urinary incontinence on quality of life can be considerable. Physically, women may experience discomfort, skin irritation, recurrent urinary tract infections and sleep disturbance due to nocturia. Functionally, the condition can restrict mobility and participation in social, occupational and physical activities. Psychologically, urinary incontinence is associated with anxiety, low mood, reduced self-esteem and social isolation. Concerns about odour, visible leakage and the need for frequent access to toilet facilities may lead to avoidance of social situations, travel and exercise. Intimate relationships and sexual function may also be adversely affected, further compounding emotional distress.

Community pharmacists are often the first healthcare professionals approached by women with bladder symptoms or those seeking continence products. The pharmacy provides an accessible and trusted setting in which sensitive health issues can be discussed confidentially. Pharmacists therefore have a key role in identifying symptoms, providing education and reassurance, reviewing medicines that may contribute to incontinence, recommending lifestyle modifications and appropriate continence aids, and facilitating timely referral to general practitioners and specialist services. A sound understanding of the types of urinary incontinence and their management is essential for pharmacists involved in the care of adult women.

Table 1: Types of Urinary Incontinence – Key Features

Types of Urinary Incontinence

Urinary incontinence is a symptom rather than a diagnosis and may arise from a variety of underlying mechanisms. It is commonly classified into stress, urge, overflow, continuous and mixed incontinence. Differentiating between these types is important, as management strategies differ.

Stress Urinary Incontinence

Stress urinary incontinence occurs when the pressure within the bladder exceeds the ability of the urethra to remain closed. This typically happens during activities that increase intra-abdominal pressure, such as coughing, sneezing, laughing, running, jumping or lifting heavy objects. The amount of urine lost may be small, such as a few drops, or may be more substantial, depending on the degree of sphincter and pelvic floor weakness.

The underlying cause is usually weakness or damage to the pelvic floor muscles and the urethral sphincter, which normally support the bladder neck and maintain continence. Pregnancy and vaginal childbirth are major risk factors, as stretching, nerve injury and trauma to the pelvic floor can compromise muscle strength and coordination. Instrumental deliveries, prolonged second stage of labour and large birth weight further increase risk. Menopause also contributes, as declining oestrogen levels lead to thinning of the urethral mucosa, reduced vascularity and loss of collagen, all of which impair the urethral closure mechanism.

Other contributing factors include hysterectomy and other pelvic surgeries, obesity, chronic cough, constipation, heavy manual work and connective tissue disorders.

Urge Urinary Incontinence and Overactive Bladder

Urge urinary incontinence is characterised by a sudden, intense desire to void that is difficult to defer and may result in leakage before the woman reaches the toilet. It is often accompanied by urinary frequency and nocturia and may be triggered by changes in posture, cold exposure or sensory stimuli such as the sound of running water. In some women, urgency and incontinence may also occur during sexual activity. The constant need to plan toilet access can significantly disrupt daily routines and reduce quality of life.

The pathophysiological basis of urge incontinence is involuntary contraction of the detrusor muscle during the bladder filling phase. This condition is commonly referred to as overactive bladder. Detrusor overactivity may be idiopathic or secondary to other conditions, including urinary tract infection, bladder stones, tumours and inflammatory disorders such as interstitial cystitis. Neurological diseases, including stroke, Parkinson’s disease, multiple sclerosis and spinal cord injury, can disrupt the neural control of bladder function and lead to urgency and incontinence. Lifestyle factors also play a role; caffeine, alcohol and artificial sweeteners can irritate the bladder and exacerbate symptoms.

Overflow Incontinence

Overflow incontinence occurs when the bladder fills but cannot empty completely, leading to chronic urinary retention and the leakage of small volumes of urine. Women may experience difficulty initiating micturition, a weak or intermittent urinary stream and a sensation of incomplete emptying. Unlike urge incontinence, the sensation of urgency may be absent or reduced.

This type of incontinence may result from impaired detrusor contractility, often due to diabetic neuropathy or neurological conditions such as multiple sclerosis and Parkinson’s disease. Obstruction of the bladder outlet can also lead to retention and overflow, for example due to pelvic organ prolapse, urethral stricture, bladder stones or tumours. Residual urine in the bladder creates an environment conducive to bacterial growth, increasing the risk of recurrent urinary tract infections and, in severe cases, upper urinary tract damage and renal impairment.

Continuous and Mixed Incontinence

Continuous or total incontinence is characterised by constant leakage of urine due to the inability of the bladder to store urine. This may be caused by severe sphincter damage, fistula formation following pelvic surgery or radiotherapy, or congenital abnormalities. Many women, however, experience mixed incontinence, most commonly a combination of stress and urge symptoms. Mixed incontinence is particularly common in older women and can be challenging to manage, as both mechanisms must be addressed.

Risk Factors

A number of factors increase the likelihood of developing urinary incontinence. These include advancing age, pregnancy and multiple vaginal deliveries, menopause and oestrogen deficiency, obesity, smoking, chronic respiratory disease associated with coughing, constipation, previous pelvic or urological surgery, neurological disorders and a family history of incontinence. Socioeconomic factors and reduced access to healthcare may also delay presentation and treatment. Awareness of these risk factors allows pharmacists to identify women who may benefit from early advice and intervention.

Medicines Associated with Urinary Incontinence

Several commonly used medicines can precipitate or exacerbate urinary incontinence by altering bladder function, urethral tone or urine production. Diuretics increase urinary output and may worsen urgency and frequency. Angiotensin-converting enzyme inhibitors can cause chronic cough, thereby aggravating stress incontinence. Alpha-blockers relax smooth muscle in the bladder neck and urethra and may reduce outlet resistance. Anticholinergic medicines, opioids and some antidepressants can impair bladder emptying and contribute to overflow incontinence. Sedatives and hypnotics may reduce awareness of bladder filling and impair mobility, increasing the risk of functional incontinence, particularly in older adults. Hormone replacement therapy may influence lower urinary tract symptoms, with variable effects.

Medication review is therefore an essential component of the pharmacist’s role. Identification of potentially contributory drugs, assessment of dose and timing, and discussion with the prescriber regarding possible alternatives can help to reduce symptom burden.

Table 2: Management Overview by Incontinence Type

Assessment in the Community Pharmacy

When a woman presents with symptoms suggestive of urinary incontinence, the pharmacist can undertake a brief but structured and sensitive assessment. This should explore the pattern and frequency of leakage, the presence of urgency, nocturia or dysuria, obstetric and surgical history, current medicines, fluid and caffeine intake and the impact of symptoms on daily activities and emotional wellbeing. The pharmacist should also be alert to red flag symptoms, such as visible haematuria, recurrent urinary tract infections, pelvic pain, unexplained weight loss or sudden onset neurological deficits, which warrant urgent medical referral.

Conservative and Lifestyle Management

Lifestyle modification forms the foundation of first-line management for most types of urinary incontinence. Adequate hydration should be encouraged, as both excessive and insufficient fluid intake can worsen symptoms. Many women restrict fluid intake in an attempt to reduce leakage, but

this can lead to concentrated urine, bladder irritation and increased risk of infection. Reduction of caffeine and alcohol consumption is particularly important in women with urgency and frequency, as these substances have diuretic and bladder-irritant effects. Weight loss in overweight and obese women can significantly improve stress incontinence by reducing intra-abdominal pressure. Smoking cessation is beneficial in reducing chronic cough and improving tissue health. Management of constipation through dietary fibre, adequate fluid intake and physical activity can reduce straining and pelvic floor stress.

Bladder training, which involves scheduled voiding and gradual extension of the interval between toilet visits, can be effective in urge incontinence. Pelvic floor muscle training is the mainstay of treatment for stress and mixed incontinence and is also beneficial in urge incontinence. Regular, correctly performed exercises strengthen the pelvic floor and improve urethral support and sphincter function. Many women benefit from referral to a specialist continence physiotherapist for assessment and supervised training. Pharmacists can reinforce the importance of adherence, as improvement may take several weeks or months and long-term maintenance is required.

Pharmacological Management

Pharmacological therapy is primarily indicated for urge urinary incontinence and overactive bladder. Antimuscarinic agents, including oxybutynin, tolterodine, solifenacin and darifenacin, reduce involuntary detrusor contractions by blocking muscarinic receptors in the bladder. The beta-3 adrenergic agonist mirabegron promotes relaxation of the detrusor

muscle during the storage phase and may be an alternative for patients who cannot tolerate antimuscarinic side effects. Common adverse effects of antimuscarinics include dry mouth, constipation, blurred vision and, particularly in older adults, potential cognitive impairment. Pharmacists have an important role in counselling patients about these effects, encouraging adherence, monitoring for drug interactions and advising on measures to alleviate side effects, such as sugar-free gum for dry mouth and adequate fibre intake for constipation.

For stress urinary incontinence, pharmacological options are limited. Duloxetine, a serotonin- noradrenaline reuptake inhibitor, may increase urethral sphincter tone and reduce leakage in some women, but its use is often limited by nausea, dizziness and withdrawal symptoms. Topical vaginal oestrogen may be beneficial for post-menopausal women with urogenital atrophy and may improve mild urinary symptoms by enhancing urethral mucosal integrity and blood flow.

Continence Products and Skin Care

Many women require continence products to manage symptoms and maintain dignity and independence while undergoing treatment or when cure is not possible. A wide range of absorbent pads, pants and bed protectors are available, varying in absorbency, size, fit and design. Product selection should be individualised, taking into account the severity and pattern of leakage, mobility, manual dexterity, skin sensitivity and lifestyle. Advice on regular changing, gentle cleansing and the use of barrier creams is important to prevent skin irritation, breakdown and infection. Pharmacists can also provide guidance on odour control and discreet disposal of used products.

Catheter Use in Women

A urinary catheter is a thin, flexible tube inserted into the bladder to allow drainage of urine when voluntary voiding is not possible or practical. Female catheters are shorter than male catheters and are designed to accommodate female anatomy. Catheterisation may be intermittent or indwelling and may be required on a short- or long-term basis depending on the underlying condition.

Indications for catheter use in women include overflow incontinence due to chronic urinary retention, acute retention following surgery or childbirth, neurological bladder dysfunction and, in some cases, palliative care. Intermittent self-catheterisation is often preferred where feasible, as it is associated with a lower risk of infection and preserves bladder function. Long-term indwelling catheters, either urethral or suprapubic, may be required in women who are unable to perform intermittent catheterisation.

While catheters can provide effective bladder drainage and reduce leakage, they are associated with complications, including urinary tract infections, blockage, encrustation, bladder spasms and urethral trauma. Education on catheter care, hand hygiene, adequate fluid intake, drainage bag management and recognition of signs of infection is essential. Community pharmacists can support patients and carers by providing advice on catheter accessories, such as leg bags and night bags, and by reinforcing the importance of prompt medical review if problems arise.

Referral Pathways and Services in Ireland

In Ireland, women with urinary incontinence are usually assessed initially by their general practitioner, who may initiate investigations, prescribe treatment or refer to specialist services. Continence advisory services, pelvic floor physiotherapy, urology and gynaecology clinics play important

roles in the assessment and management of complex cases. Public health nurses are central to the care of patients requiring catheterisation and continence support in the community. Pharmacists can assist by encouraging appropriate referral, providing information on available services and supporting adherence to treatment plans.

The Role of the Community Pharmacist

The community pharmacist has a pivotal role in the holistic management of urinary incontinence in adult women. Through sensitive communication and a non-judgemental approach, pharmacists can create an environment in which women feel comfortable discussing bladder symptoms. Early identification of incontinence, medication review, lifestyle counselling, reinforcement of pelvic floor training, recommendation of appropriate continence products and timely referral to medical and specialist services can all contribute to improved outcomes.

By normalising discussion of bladder health and providing evidence-based advice, pharmacists can help to reduce stigma, empower women to seek help and support them in managing a condition that is common, distressing and, in many cases, highly treatable.

Practice in Focus: Supporting Women with Incontinence in the Community Pharmacy – Team Communication and Merchandising

Urinary incontinence remains a highly sensitive and stigmatised condition, and many women delay seeking help due to embarrassment or fear of being overheard. The way in which continence products and advice are presented within the community pharmacy can therefore have a significant influence on whether patients feel comfortable approaching staff and accessing appropriate care. Creating a supportive, discreet and informative environment is an important part of the pharmacist’s professional role and should involve the entire pharmacy team.

From a communication perspective, all staff members, including counter assistants and technicians, should be trained to recognise common requests that may indicate underlying bladder problems, such as frequent purchases of absorbent pads, barrier creams or urinary tract infection treatments. Team members should be encouraged to respond in a calm, non-judgemental and respectful manner, using clear and empathetic language. Where possible, customers should be offered the opportunity to speak privately with the pharmacist in the consultation room. Simple phrases such as “The pharmacist is available for a confidential chat if you would like” can help open the door to further assessment without causing discomfort.

Merchandising of continence products also plays an important role in normalising the condition and improving access to care.

Locating products in a clearly labelled but discreet section of the pharmacy, rather than in hard-to- reach or hidden areas, can reduce the sense of stigma. At the same time, care should be taken to avoid positioning these products in very high-traffic or highly visible areas where customers may feel self-conscious browsing. Signage that uses positive, clinical language such as “Bladder Health” or “Continence Care” can help frame incontinence as a common medical issue rather than an embarrassing problem.

A structured range that includes light, moderate and heavy absorbency options, male and female specific products, bed protection and skincare items allows staff to make tailored recommendations based on individual need. Shelf-edge information cards or discreet leaflets outlining the different types of incontinence and available supports can empower patients to self-identify symptoms and seek advice. These materials should emphasise that effective treatments are available and that professional help can improve quality of life.

Pharmacy teams should also be familiar with local referral pathways, including general practice, continence advisory services, pelvic floor physiotherapy and public health nursing services. Being able to signpost patients to appropriate supports enhances the pharmacy’s role as an integrated part of the primary care network. In Ireland, awareness of HSE continence services and eligibility for medical card or long-term illness scheme support for certain products is particularly valuable.

Finally, regular team training and discussion can help build confidence in addressing sensitive topics such as incontinence. Role-play scenarios, updates on new products and review of communication strategies can ensure that all staff members provide consistent, compassionate and professional support. By combining thoughtful merchandising with skilled interpersonal communication, community pharmacies can create an environment in which women feel reassured, respected and empowered to seek help for urinary incontinence, ultimately improving both clinical outcomes and patient experience.